William Murphy
10Patents
3h-index
23Co-inventors
60Inventor score
Filing activity: Dec 21, 1994 → Jan 20, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5674492A | Method of preventing or treating disease characterized by neoplastic cells expressing CD40 | Chemistry; Metallurgy | 51 | Expired |
| US5837247A | Chemotactic agents for t-cells | Human Necessities | 6 | Expired |
| US7368106B2 | Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state | Human Necessities | 5 | Active |
| US7682796B2 | Compositions and methods for detection, prevention, and treatment of anthrax and other infectious diseases | Physics | 3 | Expired |
| US6562859B1 | Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of inflammation | Human Necessities | 1 | Expired |
| US11989503B2 | Formula generation by example | Physics | 0 | Active |
| US8192720B2 | Compositions and methods for detection, prevention, and treatment of anthrax and other infectious diseases | Physics | 0 | Active |
| US7175838B2 | Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state | Human Necessities | 0 | Expired |
| US9435804B2 | Detection, prevention, and treatment of anthrax and other infectious diseases | Physics | 0 | Active |
| US11960831B2 | Formula generation by example | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.